Skip to main content
SpringerLink
Log in

Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To determine the efficiency of intravenous infusion of octreotide in the treatment of patients with severe pancreatitis and pulmonary failure.

Design

Prospective, case-control study.

Setting

Intensive care unit of a university hospital.

Patients

Treatment group: 39 patients with necrotizing pancreatitis were selected for the study. In all, pulmonary failure developed under conservative treatment and surgical intervention had been necessary because of local (abscess, necrosis) or systemic (systemic inflammatory response syndrome) complications. The outcome was prospectively followed up until death or discharge from the hospital. Control group: 54 case-control matched patients with acute necrotizing pancreatitis and pulmonary failure, who had not been treated with octreotide.

Intervention

Each patient in the treatment group received 100 μg intravenous octreotide three times daily for 10 days, in addition to the standard intensive care therapy.

Results

The groups (octreotide group, control group) were highly comparable with regard to age (mean age: 54, 51 years), sex, severity of illness (Acute Physiology and Chronic Health Evaluation II score: 27, 27), etiology of pancreatitis, and pretreatment at the time of admission to the intensive care unit. There was no difference in the development of renal, hepatic, gastrointestinal, hemostatic, neurologic, or local complications. But the frequency of the adult respiratory distress syndrome (18 vs 40%;p<0.05) and circulatory shock (51 vs 87%;p<0.05) was significantly lower in the treatment group. Furthermore, mortality was 26% (10 of 39 patients) in the octreotide group and 61% (33 of 54 patients) in the control group (p<0.01).

Conclusion

The results of our case-control study showed a beneficial effect of octreotide in patients with severe necrotizing pancreatitis and pulmonary failure. Based on these data, a prospective, double-blind, placebo-controlled study should be performed to evaluate these results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bradley EL III (1993) A clinically based classification system for acute pancreatitis. Arch Surg 128: 586–590

    PubMed  Google Scholar 

  2. Marshall JB (1993) Acute pancreatitis. Arch Intern Med 153: 1185–1198

    Article  PubMed  Google Scholar 

  3. Löser C, Fölsch UR (1993) A concept of treatment in acute pancreatitis — results of controlled trials, and future developments. Hepatogastroenterology 40: 569–573

    PubMed  Google Scholar 

  4. Lembke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I (1987) Effect of the somatostatin analogue Sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 36: 108–124

    PubMed  Google Scholar 

  5. Szabo S, Usadel KH (1982) Cytoprotection-organoprotection by somatostatin: gastric and hepatic lesions. Experimentia 38: 254–256

    Article  Google Scholar 

  6. Usadel KH, Kessler H, Rohr G, Kusterer K, Palitsch KD, Schwedes U. (1986) Cytoprotective properties of somatostatins. Klin Wochenschr 64 [Suppl 7]: 59–63

    PubMed  Google Scholar 

  7. Jenkins SA, Baxter JN, Day DW, Al-Sumidaie AM, Leinster SJ, Shields R (1986) The effects of somatostatin and SMS 201-995 on experimentally-induced pancreatitis and endotoxinemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension. Klin Wochenschr 64 [Suppl 7]: 100–106

    Article  PubMed  Google Scholar 

  8. Usadel KH, Überla KK, Leuschner U (1985) Treatment of acute pancreatitis with somatostatin: results of the multicenter double-blind trial (APTS-study). Dig Dis Sci 30: 992

    Google Scholar 

  9. Choi TK, Mok F, Zhan WH, Fan ST, Lai ECS, Wong J (1989) Somatostatin in the treatment of acute pancreatitis: a prospective randomized controlled trial. Gut 30: 223–227

    PubMed  Google Scholar 

  10. D'Amico D, Favia G, Biasiato R, Casaccia M, Falcone F, Fersini M, Marrano D, Neapolitano F, Oliviero S, Rodolico A (1990) The use of somatostatin in acute pancreatitis — results of a multicenter trial. Hepatogastroenterology 37: 92–98

    PubMed  Google Scholar 

  11. Gjorup I, Roikjaer O, Anderson B, Burcharth F, Hovendal C, Pedersen SA, Christiansen P, Wara P, Andersen JC, Balslev I, Jepsen J, Rokkjaer M (1992) A double-blinded multicenter trial of somatostatin in the treatment of acute pancreatitis. J Am Coll Surg 175: 397–400

    Google Scholar 

  12. Beechy-Newman N (1993) Controlled trial of high-dose octreotide in treatment of acute pancreatitis. Dig Dis Sci 38: 644–647

    Article  PubMed  Google Scholar 

  13. Binder M, Uhl W, Friess, Malfertheiner P, Büchler MW (1994) Octreotide in the treatment of acute pancreatitis: results of a unicenter prospective trial with three different octreotide dosages. Digestion 55 [Suppl 1]: 20–23

    PubMed  Google Scholar 

  14. Steinberg WM, Schlesselman SE (1987) Treatment of acute pancreatitis. Gastroenterology 93: 1420–1427

    PubMed  Google Scholar 

  15. Trede M, Carter DC (eds) (1993) Surgery of the pancreas. Churchill Livingstone, Edinburgh, London, New York

    Google Scholar 

  16. Beger HG, Büchler M (eds) (1987) Acute pancreatitis. Springer, Berlin, Heidelberg, New York

    Google Scholar 

  17. Ranson JHC, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC (1974) Prognostic signs and the role of operative management in acute pancreatitis. J Am Coll Surg 139: 69–81

    Google Scholar 

  18. Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC (1984) Prognostic factors in acute pancreatitis. Gut 25: 1340–1346

    PubMed  Google Scholar 

  19. Wilson C, Heath DI, Imrie CW (1990) Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 77: 1260–1264

    PubMed  Google Scholar 

  20. Balthazar EJ, Ranson JHC, Naidich DP, Megibow AJ, Caccavale R, Cooper MM (1990) Acute pancreatitis: prognostic value of CT. Radiology 156: 767–772

    Google Scholar 

  21. Schölmerich J, Heinisch A, Leser HG. (1993) Diagnostic approach to acute pancreatitis: diagnosis, assessment of etiology and prognosis. Hepatogastroenterology 40: 531–537

    PubMed  Google Scholar 

  22. Larvin M, McMahon MJ (1989) APACHE II score for assessment and monitoring of acute pancreatitis. Lancet II 201–205

    Article  Google Scholar 

  23. Mayer DA, McMahon MJ, Corfield AP, Cooper MJ, Williamson RCN, Dickson AP, Shearer MG, Imrie CM (1985) Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med 312: 399–404

    PubMed  Google Scholar 

  24. Büchler M, Malfertheiner P, Uhl W, Schölmerich J, Stöckmann F, Adler G, Gaus W, Beger HG, and the German Pancreatitis Study Group (1993) Gabexate mesilate in human acute pancreatitis. Gastroenterology 104: 1165–1170

    PubMed  Google Scholar 

  25. Medical Research Council Multicentre Trial (1980) Morbidity of acute pancreatitis: the effect of aprotinin and glucagon. Gut 21: 334–339

    Google Scholar 

  26. Fan ST, Lai ECS, Mok FPT, Lo CM, Zheng SS, Wong J. (1993) Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med 328: 228–232

    Article  PubMed  Google Scholar 

  27. Leese T, Holliday M, Heath D, Hall AW, Bell PRF (1987) Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 74: 907–911

    PubMed  Google Scholar 

  28. Niederau C, Heise JW, Lüthen R, Becker H (1994) Systemische Komplikationen bei akuter Pankreatitis. Med Klin 89 [suppl 1]: 89

    PubMed  Google Scholar 

  29. Carballo F, Dominguez E, Fernandez-Calvet L, Martinez-Pancorbo C, Garcia A, De la Morena J (1991) Is somatostatin useful in the treatment of acute pancreatitis? A meta-analysis. Digestion 49: 12–13

    Google Scholar 

  30. Kutz K, Nuesch E, Rosenthaler J (1986) Pharmacokinetics of SMS 201–995 in healthy subjects. Scand J Gastroenterol 21 [Suppl] 65–72

    PubMed  Google Scholar 

  31. Kallivretakis N, Yotis A, del Pozo E (1985) Pharmacokinetics of SMS 201-995 in normal subjects and in patients with severe renal failure. Neuroendocrinol Lett 7: 92–95

    Google Scholar 

  32. Peffer F, Büsing M, Becker HD, Hopt UT (1993) Gibt es eine akute, exokrine Pankreasinsuffizienz? Langenbecks Arch Chir [Suppl] 227–231

  33. Van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Löwenberg B, Lamberts SWJ (1994) Somatostatin and the immune and haematopoietic system: a review. Eur J Clin Invest 24: 91–99

    PubMed  Google Scholar 

  34. Dal Nogare AR (1989) Southwestern Internal Medicine Conference: adult respiratory distress syndrome. Am J Med Sci 298: 413–430

    PubMed  Google Scholar 

  35. Bellomo R (1992) The cytokine network in critically ill. Anaesth Intensive Care 20: 288–302

    PubMed  Google Scholar 

  36. Balibrea-Cantero JL, Arias-Diaz J, Garcia C, Torres-Melero J, Simon C, Rodriguez JM, Vara E. (1994) Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-alpha in human type II pneumocytes. Am J Respir Crit Care Med 149: 699–706

    PubMed  Google Scholar 

  37. Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Amer Rev resp Dis 132: 720–726

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Anästhesiologie und Intensivmedizin, Klinikum Mannheim, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Theodor Kutzer Ufer, D-68167, Mannheim, Germany

    F. Fiedler, G. Jauernig & H. J. Bender

  2. Medizinische Klinik und Poliklinik II, Universität Leipzig, Leipzig, Germany

    V. Keim

  3. Chirurgische Klinik, Klinikum Mannheim, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Mannheim, Germany

    A. Richter

Authors
  1. F. Fiedler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Jauernig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Keim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. J. Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fiedler, F., Jauernig, G., Keim, V. et al. Octreotide treatment in patients with necrotizing pancreatitis and pulmonary failure. Intensive Care Med 22, 909–915 (1996). https://doi.org/10.1007/BF02044115

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02044115

Key words

Search

Navigation